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Abstract 
 
Granulomatosis with polyangiitis (GPA) is a rare but serious small vessel vasculitis with  
heterogeneous clinical presentation ranging from mainly localised disease with a chronic course, 
to a florid, acute small vessel vasculitic form characterised by severe pulmonary haemorrhage 
and/or rapidly progressive vasculitis or other severe systemic vasculitic manifestations. Cardiac 
involvement is, however, uncommon. We report a case of a 16 year-old male who presented with 
peripheral gangrene and tricuspid valve vegetation, initially considered to have bacterial 
endocarditis but ultimately diagnosed with GPA. We provide an overview of the literature 
relating to cardiac involvement in GPA, and the diagnostic challenge relating to infective 
endocarditis in this context. 
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Granulomatosis with polyangiitis (formerly Wegener’s granulomatosis) is characterized by 
granulomatous inflammation involving the respiratory tract, with necrotizing vasculitis affecting 
small to medium-sized vessels (e.g. capillaries, venules, arterioles, and arteries). The disease may 
present in two non-mutually exclusive forms: a predominantly granulomatous disease with 
mainly localised disease affecting the respiratory tract or orbits; and a florid, acute small vessel 
vasculitic form characterised by severe pulmonary haemorrhage and/or rapidly progressive 
glomerulonephritis or other severe systemic vasculitic manifestations. Cardiac involvement is 
uncommon [1,2,3], but when it does occur the features can mimic infective endocarditis, leading 
to diagnostic delay. Furthermore, anti-neutrophil cytoplasmic antibodies (ANCA) have been 
reported to be present in some cases of true infective endocarditis, adding to the diagnostic 
confusion [ref]. We report a case of a 16 year-old male with GPA who first presented with 
tricuspid valve vegetation, peripheral gangrene, and renal impairment initially considered to be 
due to infective endocarditis. We provide an overview of the literature relating to cardiac 
involvement in GPA. 
 
A previously fit and well Caucasian 16 year-old male presented with a four week history of 
pyrexia, dyspnoea, anorexia and weight loss, without any obvious focus of infection. Examination 
revealed an extremely unwell adolescent male with fever of 39.0oC, respiratory distress and dry 
gangrene of his toes and right forefoot (Figure 1A), with absence of peripheral pulses in the right 
foot. The pulps of his toes on the left were also ischaemic, but not gangrenous. Investigations 
revealed neutrophil leucocytosis: white cell count 32.27 x109/L (reference range [RR] 4-11), 
neutrophils 27.21 x109/L (RR 2-7), thrombocytosis 648 x109/L (RR 150-450), haemoglobin 9.3 
g/dl (RR 13.0-16.0). Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were 
elevated at 105 mm/h (RR <10 mm/h); and >270 mg/L (RR <20mg/L) respectively. Creatinine 
was 290 umol/l (RR 55-96 umol/l) and the urine albumin/creatinine ratio was 509 mg/mmol (RR 
<11.3). Urine, sputum and repeated blood cultures, including fungal cultures, were sterile. The 
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chest radiograph showed a right  pleural  effusion  with  underlying  ground-glass  attenuation  in  
the  right  lung. The patient also developed acute testicular pain requiring surgical exploration, 
which revealed a haematoma and infarction of the epididymis in the upper pole of the right testis. 
Echocardiography revealed a vegetation adjacent to the tricuspid valve, suggestive of infective 
endocarditis (Figure 1B), with possible secondary embolus causing ischaemia of the peripheries. 
In that context, the patient did not have any history of drug or substance abuse. 
 
He was treated initially with broad spectrum antibiotics (cefotaxime, vancomycin, gentamicin, 
doxycicline) and antifungals (ambisome and fluconazole); he was also started on  intravenous 
heparin and alteplase (recombinant tissue plasminogen activator), with poor response indicated by 
further deterioration of the gangrene, and ongoing severe systemic inflammation. 
 
Subsequent investigations revealed strongly positive anti neutrophil cytoplasmic antibodies 
against proteinase 3 (PR3-ANCA: 194 EU/ml; RR <1.99). Computer tomography (CT) of his 
chest revealed segmental consolidations with widespread ground glass change/nodules (Figure 
1C). Renal biopsy showed acute segmental necrotizing glomerulonephritis with expansive 
crescents (Figure 1D). The combination of renal and pulmonary findings, with strongly positive 
PR3-ANCA confirmed a diagnosis of GPA, complicated by triscupid valve involvement. 
Retrospectively, the patient gave a history of recurrent epistaxis for months prior to his acute 
presentation. 
 
He received treatment with intravenous methylprednisolone (1g daily for 3 consecutive days) 
followed by high dose oral Prednisolone; ten days of therapeutic plasma exchange; rituximab (1g 
twice, two weeks apart) and intravenous cyclophosphamide (500 mg/m2 every 3 weeks for 4 
doses; cumulative dose  3.32 g) with prompt recovery of symptoms, resolution of the acute-phase 
response, and normalization of renal function. He later went on to have an amputation of the 
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gangrenous toes on the right foot, which healed uneventfully (Figure 1E). At transition to adult 
care at the age of eighteen years old he was in remission on treatment with Prednisolone 3mg 
once a day, Azathioprine 125 mg once a day and Amlodipine 5 mg once a day; creatinine was 
within normal range at 71 umol/l, although he still had mild-to-moderate albuminuria (35.9 
mg/mmol).  
 
Discussion 
GPA is a rare but serious systemic autoimmune small vessel vasculitis. Although cardiac 
involvement is rare (6%-17%), it can be a serious complication associated with mortality, and 
may delay the diagnosis and treatment of GPA by mimicking infective endocarditis. Hence 
recognizing that GPA can involve the heart (including cardiac valves) is important in order to 
secure a prompt diagnosis and initiate appropriate therapy as early as possible[4,5]. Cardiac 
involvement in GPA is usually secondary to necrotizing vasculitis, with or without 
granulomatous infiltrates [ref]. Pericarditis and coronary vasculitis are the most frequent findings, 
but myocarditis, endocarditis, and conduction system granulomata are also described [ref]. The 
clinical presentation is very heterogeneous, ranging from subclinical manifestations, of which 
arrhythmia is the most common, to end-stage heart failure due to either myocardial infarct, 
valvular rupture or complete heart block.  Valvular involvement is extremely rare, with aortic 
regurgitation, mitral regurgitation and aortic stenosis the most common findings described, 
usually associated with sterile valvular vegetations [6], as in the case described herein. Table 1 
describes all reported cardiac manifestations in GPA. 
 
To add to the diagnostic uncertainty, there have been reports of true infective endocarditis with 
transient ANCA positivity. We suggest that patients with cardiac valve vegetations who have 
other compelling clinical features of GPA (for example pauci-immune segmental necrotising 
glomerular nephritis, as in our case), with strongly positive ANCA, are most likely to have 
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ANCA associated vasculitis and should be treated as such. Clinicians may consider initiating 
immunosuppressive treatment combined with broad-spectrum antibiotics cover if there is ongoing 
concern regarding true infective endocarditis, however. Lastly, we emphasise that patients with 
established AAV who are immunosuppressed may be prone to opportunistic infection including 
infective endocarditis [ref], and the clinician must remain ever vigilant for this possibility.  
 
In conclusion, we emphasise that cardiac valve vegetations in a febrile patient should not  
invariably be considered to be indicative of infective endocarditis, since GPA may also cause 
valve inflammation and sterile endocarditis. Whilst previous reports have suggested that patients 
with endocarditis may have transient ANCA positivity, this is rare and in the presence of other 
features of systemic vasculitis detection of ANCA usually indicates the presence of a true ANCA 
associated vasculitis.   
 
Key messages: 
1. Early recognition of possible cardiac involvement in GPA is crucial in order to promptly  
initiate and treatment and reduced the morbidity and mortality associated with this 
disease. 
2. GPA should be considered in  the differential diagnosis of young risk factor free patients 
presenting with presumed infective endocarditis. 
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